Towards Healthcare
Human Microbiome Market to Reach at 30.97% CAGR till 2034

Human Microbiome Market 2025 Size, Growth Drivers, and Projected Expansion to 2034

Market insights predict the global human microbiome industry will increase from USD 0.94 billion in 2024 to USD 13.87 billion by 2034, achieving a CAGR of 30.97%. The market is growing due to rising research on the role of gut health in chronic diseases and increasing demand for microbiome-based therapeutics. Additionally, advancements in sequencing technologies and personalized medicine are driving market expansion. North America is leading due to the rising focus on gut health among Americans. 

Content

  • Insight Code: 6042
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The human microbiome market in 2025 is valued at USD 1.23 billion and is projected to climb to USD 13.87 billion by 2034, with a CAGR of 30.97% over the forecast period.

North America is currently leading the human microbiome market due to widespread use of advanced imaging technologies and a mature healthcare system.

Some key players include Finch Therapeutics, Vedanta Biosciences, Ferring Pharmaceuticals, MaaT Pharma, BiomX Inc., 4D pharma plc, and Synlogic.

It plays a key role in digestion, immunity, metabolism, and even mental health by interacting with the body systems and influencing biological processes.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions